120 STAT. 2294
PUBLIC LAW 109–364—OCT. 17, 2006 (C) An assessment of how the Department incorporates medical quality into performance measures for military and civilian health care providers within the military health care system. (D) An assessment of the patient safety programs of the Department. (E) A description of the extent to which the Department seeks to address particular medical errors, and an assessment of the adequacy of such efforts. (F) An assessment of accountability within the military health care system for preventable negative outcomes involving negligence. (G) An assessment of the performance of the health care safety and quality measures of the Department. (H) An assessment of the collaboration of the Department with national initiatives to develop evidence-based quality measures and intervention strategies, especially the initiatives of the Agency for Health Care Research and Quality within the Department of Health and Human Services. (I) A comparison of the methods, mechanisms, and programs and activities referred to in subparagraphs (A) through (G) with similar methods, mechanisms, programs, and activities used in other public and private health care systems and organizations. (3) REPORT.— (A) IN GENERAL.—Not later than one year after the date of the enactment of this Act, the Secretary shall submit to the Committees on Armed Services of the Senate and the House of Representatives a report on the review required pursuant to paragraph (1). (B) ELEMENTS.—The report required by subparagraph (A) shall include the following: (i) The results of the review required pursuant to paragraph (1). (ii) A discussion of recent highlights in the accomplishments of the Department of Defense medical quality assurance program. (iii) Such recommendations for legislative or administrative action as the Secretary considers appropriate for the improvement of the program.
SEC. 720. REPORT ON DISTRIBUTION OF HEMOSTATIC AGENTS FOR USE IN THE FIELD.
Not later than 60 days after the date of the enactment of this Act, the Secretary of Defense shall submit to the congressional defense committees a report on the distribution of hemostatic agents to members of the Armed Forces serving in Iraq and Afghanistan, including a description of any distribution problems and attempts to resolve such problems. SEC. 721. LONGITUDINAL STUDY ON TRAUMATIC BRAIN INJURY INCURRED BY MEMBERS OF THE ARMED FORCES IN OPERATION IRAQI FREEDOM AND OPERATION ENDURING FREEDOM.
(a) STUDY REQUIRED.—The Secretary of Defense shall conduct a longitudinal study on the effects of traumatic brain injury incurred by members of the Armed Forces serving in Operation Iraqi
VerDate 14-DEC-2004
13:05 Jul 12, 2007
Jkt 059194
PO 00002
Frm 01038
Fmt 6580
Sfmt 6581
E:\PUBLAW\PUBL002.109
APPS06
PsN: PUBL002
�
